Hutu80 and NCI h716 treatment with SCFAs and α synuclein Western Blotting
Output Details
Description
This protocol describe the treatment of human enteroendocrine cell models Hutu80 and NCI h716 parental cells with SCFAs and GCase inhibitor (CBE) in order to detect the impact of SCFAs and GCAse inhibition on alpha synuclein protein expression by immunoblotting.